Vaxxinova US Announces USDA Approval of Vaxxon® SRP® Pasteurella
March 15, 2021 – Wilmar, MN, USA Vaxxinova US is announcing USDA approval of their new Vaxxon® SRP® Pasteurella vaccine. Categorized by USDA as a Pasteurella Multocida Bacterial Extract, it is an effective, innovative and safe vaccine against fowl cholera in chickens. Vaxxon SRP Pasteurella provides the industry a new category for long-term protection of […]
Read more →
Vaxxinova US gains market rights to SRP cattle vaccine from Zoetis
Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]
Read more →
“Boerderij” article on autogenous vaccines
Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here.
Read more →
Vaxxinova®
Vaxxinova® is committed to disease prevention in livestock. We aim to provide a complete set of vaccines and diagnostic services, supported by our global R&D network. Vaxxinova believes in ‘business without borders’ and long term partnerships with livestock veterinarians and animal health professionals. We work together in disease prevention and livestock performance improvement programs. Our technical teams can advise you on our products and services.